BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11430507)

  • 1. Improving on PPI-based therapy of GORD.
    Sachs G
    Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S35-41. PubMed ID: 11430507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases.
    Andersson K; Carlsson E
    Pharmacol Ther; 2005 Dec; 108(3):294-307. PubMed ID: 16000224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological targets in gastro-oesophageal reflux disease.
    Piche T; Galmiche JP
    Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):333-41. PubMed ID: 16364047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-demand therapy for gastro-oesophageal reflux disease.
    Bytzer P
    Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S19-22. PubMed ID: 11430504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developments in the inhibition of gastric acid secretion.
    Mössner J; Caca K
    Eur J Clin Invest; 2005 Aug; 35(8):469-75. PubMed ID: 16101666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shortcomings of the first-generation proton pump inhibitors.
    Tytgat GN
    Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S29-33. PubMed ID: 11430506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors.
    Shin JM; Cho YM; Sachs G
    J Am Chem Soc; 2004 Jun; 126(25):7800-11. PubMed ID: 15212527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibition. An effective, safe approach to GERD management.
    Berardi RR
    Postgrad Med; 2001 Oct; Spec No():24-35. PubMed ID: 11868428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
    Inadomi JM; McIntyre L; Bernard L; Fendrick AM
    Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are there unmet needs in acid suppression?
    Tytgat GN
    Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():67-72. PubMed ID: 15588797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: the clinical pharmacology of proton pump inhibitors.
    Sachs G; Shin JM; Howden CW
    Aliment Pharmacol Ther; 2006 Jun; 23 Suppl 2():2-8. PubMed ID: 16700898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic approaches to reflux disease, focusing on acid secretion.
    Kinoshita Y; Adachi K; Fujishiro H
    J Gastroenterol; 2003 Mar; 38 Suppl 15():13-9. PubMed ID: 12698865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
    Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
    J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharyngolaryngeal reflux in outpatient clinical practice: personal experience.
    Galli J; Scarano S; Agostino S; Quaranta N; Cammarota G; Ottaviani F
    Acta Otorhinolaryngol Ital; 2003 Feb; 23(1):38-42. PubMed ID: 12812134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory gastrooesophageal reflux disease.
    Bredenoord AJ; Smout AJ
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):217-23. PubMed ID: 18301303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitors in the elderly population.
    Whitaker M
    Eur J Gastroenterol Hepatol; 2002 Sep; 14 Suppl 1():S5-9. PubMed ID: 12570023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term cost effectiveness and long-term cost analysis comparing laparoscopic Nissen fundoplication with proton-pump inhibitor maintenance for gastro-oesophageal reflux disease.
    Cookson R; Flood C; Koo B; Mahon D; Rhodes M
    Br J Surg; 2005 Jun; 92(6):700-6. PubMed ID: 15852426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitors: the beginning of the end or the end of the beginning?
    Scarpignato C; Hunt RH
    Curr Opin Pharmacol; 2008 Dec; 8(6):677-84. PubMed ID: 18840545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.